Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity.
about
Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathwayThe prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balancePlatelets as predictors of vascular risk: is there a practical index of platelet activity?Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjectsState-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.A novel small molecule 1,2,3,4,6-penta-O-galloyl-α-D-glucopyranose mimics the antiplatelet actions of insulinThe association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study.Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation.Coagulation and fibrinolysis abnormalities in obesity.Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspectiveThe metabolic syndrome: an emerging risk state for cardiovascular disease.Postprandial platelet activation is related to postprandial plasma insulin rather than glucose in patients with type 2 diabetes.Platelet function in the postprandial periodClinical characteristics associated with high on-treatment platelet reactivity of patients undergoing PCI after a 300 mg loading dose of clopidogrel, measured by thrombelastographyDiabetes mellitus as a prothrombotic condition.Exacerbation of glycoprotein VI-dependent platelet responses in a rhesus monkey model of Type 1 diabetesFactors contributing to increased platelet reactivity in people with diabetesDiabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularizationHyperglycemia: a prothrombotic factor?Platelet function profiles in patients with diabetes mellitus.Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.Platelet hyperaggregability in obesity: is there a role for nitric oxide impairment and oxidative stress?Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy.Acute effect of a high-carbohydrate low-fat meal on platelet aggregation.IRS-1 mediates inhibition of Ca2+ mobilization by insulin via the inhibitory G-protein Gi.Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity.Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction.Local insulin application on the carotid artery inhibits neointima formation.The effect of weight loss on the mean platelet volume in obese patients.Postprandial platelet aggregation: effects of different meals and glycemic index.
P2860
Q24306460-4DC3BABC-FDA7-40C8-800F-F36A170469FAQ27003277-2C0EC331-14D4-457F-BFF4-6DE0D3D4487DQ28165430-B36178AB-C4EF-4E33-BAA7-9E5C982917CDQ28196731-7FAE021A-9D5F-4EEC-B775-EEBDE74B3FBEQ30373414-4BDB4B9E-97B4-454E-98FB-A4206FDB96FFQ34002877-2D5F9D55-E6D6-4B8D-A8A1-96F6121B7761Q34071537-332DECEF-1BB0-4023-82D0-33FE63C25E95Q34476667-677C263A-1D6F-43B3-98A7-D090983E0389Q34816571-338E11FC-3E6E-4DF6-A143-8957E4AFAD08Q35037271-8A1A6E85-19BD-428A-AE19-807BE54E4527Q35174193-8A13AA5F-F069-4AC9-A6C3-F4501C761A02Q35824621-1A7110AC-6280-4DAD-83C7-E6EB1C142A62Q36182535-23581570-D193-4A9A-99DC-66CC05A235BCQ36411981-CAA9D948-4D29-414F-B2A4-8701D26C4E6BQ36800844-9EA4D4E7-EBCC-4127-9FC5-6E166346824DQ36889156-CCA731C4-C107-4292-B72D-69282C70FC8AQ36948558-8C8724F8-11A9-41F4-92BB-99F0C8C06C91Q37139534-93FC4747-AD32-4244-BB77-F8D791FC8BAAQ37167506-F3848F23-4CE9-4573-89FC-2082C0C26EEDQ37759238-5F9004D4-CAE9-4960-8653-85122D6156D3Q38081078-AACF9FF1-38F2-4756-8EC9-83D516EE3444Q38381704-D032E967-49F6-4900-ADC1-DDE5DF5A1109Q38871719-39EE8E4B-53D0-4599-835C-CB355C2BFE67Q39660267-3C7D49B4-47D6-4EB0-89B5-8446B4CF4242Q43237787-43CF6263-67B4-476A-BFBD-8D7A4A47B349Q44645484-B788DA6C-0AE6-43DA-8127-0E7D46257D86Q44980053-04A91CBC-2F25-4BE6-A15B-A1F8615FD20CQ45824389-DBEDB880-DE8B-44BC-B2C7-8579E7537C5DQ46832582-4066E8DC-E8D1-4CC9-A7DE-5EF4917FF262Q47288691-313E8541-4C75-4DC9-A598-E76FADB7B2AEQ51359414-692CA209-93A8-43CF-AD3F-D5EDFAEC956E
P2860
Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Inhibition of platelet-collage ...... insulin resistance in obesity.
@en
Inhibition of platelet-collage ...... insulin resistance in obesity.
@nl
type
label
Inhibition of platelet-collage ...... insulin resistance in obesity.
@en
Inhibition of platelet-collage ...... insulin resistance in obesity.
@nl
prefLabel
Inhibition of platelet-collage ...... insulin resistance in obesity.
@en
Inhibition of platelet-collage ...... insulin resistance in obesity.
@nl
P2093
P356
P1476
Inhibition of platelet-collage ...... insulin resistance in obesity.
@en
P2093
Aila Rissanen
Anu Turpeinen
Jukka Westerbacka
Martti Syrjälä
Riitta Lassila
Satu Vehkavaara
P304
P356
10.1161/HQ0102.101546
P407
P577
2002-01-01T00:00:00Z